Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

In addition to the potential connection between microplastics and cancer, research has linked ongoing exposure to lung ...

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

Medical experts in the UK have discovered two lesser-known symptoms of lung cancer. These symptoms are finger clubbing and ...

Johnson & Johnson said it received positive topline results in a Phase 3 study of a combination of drugs to treat patients with locally advanced or metastatic non-small cell lung cancer.

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

Scientists discover surprising link between dietary fat and lung cancer risk. New study shows how changing what you eat might help protect your lungs.

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first patient has been ...

Identifying lung cancer at its earliest stage before symptoms develop allows for earlier treatment and the potential for cure ...

Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.